17α-Acetoxy-6-methylene-pregn-4-ene-3,20-dione
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
With ethanol; 5%-palladium/activated carbon In cyclohexene at 75 - 78℃; for 5h; Reagent/catalyst; Temperature; | 87.5% |
With sodium acetate; cyclohexene; palladium on activated charcoal In ethanol; water Heating / reflux; |
3-cycloethylenedioxy-6-methyl-17α-acetoxy-pregn-5-ene-20-one
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
With silica gel; copper(II) sulfate In chloroform for 2h; Heating; | 81% |
Conditions | Yield |
---|---|
With cyclohexanone; aluminum isopropoxide; toluene | |
With aluminum isopropoxide |
Conditions | Yield |
---|---|
With hydrogenchloride |
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid; acetic acid |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
With hydrogen; palladium on activated charcoal In methanol |
Conditions | Yield |
---|---|
Multi-step reaction with 7 steps 1: benzene; toluene-4-sulfonic acid 2: peroxybenzoic acid; chloroform 3: benzene; diethyl ether 4: aqueous methanol.H2SO4 5: CrO3; pyridine 6: aqueous HCl 7: acetic acid; toluene-4-sulfonic acid View Scheme |
3β,5,17-trihydroxy-6β-methyl-5α-pregnan-20-one
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: CrO3; pyridine 2: aqueous HCl 3: acetic acid; toluene-4-sulfonic acid View Scheme |
5,17-dihydroxy-6β-methyl-5α-pregnane-3,20-dione
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: aqueous HCl 2: acetic acid; toluene-4-sulfonic acid View Scheme | |
Multi-step reaction with 2 steps 1: HCl; CHCl3 2: acetic acid; toluene-4-sulfonic acid View Scheme | |
Multi-step reaction with 3 steps 1: pyridine; aq. NaOH solution 2: HCl; CHCl3 3: acetic acid; toluene-4-sulfonic acid View Scheme |
20,20-ethanediyldioxy-6β-methyl-5α-pregnane-3β,5,17-triol
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: aqueous methanol.H2SO4 2: CrO3; pyridine 3: aqueous HCl 4: acetic acid; toluene-4-sulfonic acid View Scheme |
3β-acetoxy-20,20-ethanediyldioxy-pregn-5-en-17-ol
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1: peroxybenzoic acid; chloroform 2: benzene; diethyl ether 3: aqueous methanol.H2SO4 4: CrO3; pyridine 5: aqueous HCl 6: acetic acid; toluene-4-sulfonic acid View Scheme |
3β-acetoxy-20,20-ethanediyldioxy-5,6α-epoxy-5α-pregnan-17-ol
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: benzene; diethyl ether 2: aqueous methanol.H2SO4 3: CrO3; pyridine 4: aqueous HCl 5: acetic acid; toluene-4-sulfonic acid View Scheme |
6-methylpregn-5-ene-3β,17α-diol-20-one diacetate
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: aqueous methanol. HCl 2: cyclohexanone; aluminium isopropylate; toluene View Scheme |
17-hydroxy-6β-methyl-pregn-4-ene-3,20-dione
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: HCl; CHCl3 2: acetic acid; toluene-4-sulfonic acid View Scheme |
3,3;20,20-bis-ethanediyldioxy-6β-methyl-5α-pregnane-5,17-diol
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: acetone / saure Hydrolyse 2: HCl; CHCl3 3: acetic acid; toluene-4-sulfonic acid View Scheme | |
Multi-step reaction with 4 steps 1: acetone / saure Hydrolyse 2: pyridine; aq. NaOH solution 3: HCl; CHCl3 4: acetic acid; toluene-4-sulfonic acid View Scheme |
17-hydroxy-5-pregnene-3,20-dione 3,20-bisethylene ketal
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: peroxyacetic acid 2: tetrahydrofuran 3: acetone / saure Hydrolyse 4: HCl; CHCl3 5: acetic acid; toluene-4-sulfonic acid View Scheme | |
Multi-step reaction with 6 steps 1: peroxyacetic acid 2: tetrahydrofuran 3: acetone / saure Hydrolyse 4: pyridine; aq. NaOH solution 5: HCl; CHCl3 6: acetic acid; toluene-4-sulfonic acid View Scheme |
3,3;20,20-bis-ethanediyldioxy-5,6α-epoxy-5α-pregnan-17-ol
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: tetrahydrofuran 2: acetone / saure Hydrolyse 3: HCl; CHCl3 4: acetic acid; toluene-4-sulfonic acid View Scheme | |
Multi-step reaction with 5 steps 1: tetrahydrofuran 2: acetone / saure Hydrolyse 3: pyridine; aq. NaOH solution 4: HCl; CHCl3 5: acetic acid; toluene-4-sulfonic acid View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: acetic acid; toluene-4-sulfonic acid 2: methanol.HCl View Scheme |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: aq. HCl 2: Al(OiPr)3 View Scheme |
Conditions | Yield |
---|---|
With rhodium(III) chloride hydrate In methanol for 2.5h; Michael addition; Reflux; diastereoselective reaction; | 95% |
Conditions | Yield |
---|---|
With rhodium(III) chloride hydrate In methanol for 6h; Michael addition; Reflux; diastereoselective reaction; | 78% |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
With Absidia griseollavar. igachii In ethanol at 25℃; for 240h; Reagent/catalyst; Temperature; Microbiological reaction; regioselective reaction; | 63% |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
Stage #1: Medroxyprogesterone acetate With C19H26ClIrN3O(1+)*Cl(1-) In water at 80℃; for 0.166667h; Stage #2: With formic acid In water at 80℃; for 4h; regioselective reaction; | 62% |
Conditions | Yield |
---|---|
With chloranil | |
With 2-methyl-propan-1-ol; chloranil Heating; | |
With chloranil | |
Multi-step reaction with 2 steps 1: TsOH / dioxane 2: (tBuO)2CrO2, Ac2O / CCl4 View Scheme |
Conditions | Yield |
---|---|
With pyridine; selenium(IV) oxide; tert-butyl alcohol |
Conditions | Yield |
---|---|
With potassium hydroxide | |
With water; sodium hydroxide In methanol for 5h; Reflux; |
Medroxyprogesterone acetate
chloranil
acetic acid
ethyl acetate
Megestrol acetate
Medroxyprogesterone acetate
chloranil
tert-butyl alcohol
Megestrol acetate
Medroxyprogesterone acetate
propionic acid anhydride
17-acetoxy-6-methyl-3-propionyloxy-pregna-3,5-dien-20-one
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
(i) MeNH2, MeOH, (ii) aq. Ca(OCl)2, NH3, OTs; Multistep reaction; |
Medroxyprogesterone acetate
trichloroacetic acid anhydride
17α-Acetoxy-3-trichloracetoxy-6-methyl-Δ3,5-pregnadien-20-on
Conditions | Yield |
---|---|
With lithium tri(t-butoxy)aluminum hydride In tetrahydrofuran at 0℃; |
Medroxyprogesterone acetate
A
17α-acetoxy-3α-hydroxy-6α-methyl-5α-pregnan-20-one
B
17α-acetoxy-3β-hydroxy-6α-methyl-5α-pregnan-20-one
C
17α-acetoxy-3α-hydroxy-6α-methyl-5β-pregnan-20-one
D
17α-acetoxy-3β-hydroxy-6α-methyl-5β-pregnan-20-one
Conditions | Yield |
---|---|
With hydrogen; Rh on carbon In ethanol; acetic acid for 48h; Yield given. Yields of byproduct given; |
Medroxyprogesterone acetate
17α-acetoxy-6α-methyl-5β-pregnane-3,20-dione
Conditions | Yield |
---|---|
With hydrogen; palladium on activated charcoal In ethyl acetate | |
With hydrogen; Lindlar's catalyst In pyridine for 24h; | 6.9 g |
Medroxyprogesterone acetate
6α-methylpregn-4-ene-3α,17α-diol-20-one 17-acetate
Conditions | Yield |
---|---|
With lithium tri-sec-butyl(hydrido)borate In tetrahydrofuran at -78℃; |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
With N,N-dimethyl-formamide; trichlorophosphate |
Medroxyprogesterone acetate
Conditions | Yield |
---|---|
(i) H2, Pd-C, AcOEt, (ii) LiAlH4, Et2O, (iii) aq. NaIO4, AcOH, EtOH; Multistep reaction; |
Conditions | Yield |
---|---|
With triethylamine In ethanol |
Medroxyprogesterone acetate
trimethyl orthoformate
3-Methoxy-17α-acetoxy-6-methyl-pregnadien-(3,5)-on-(20)
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In 1,4-dioxane |
pyridine
selenium(IV) oxide
Medroxyprogesterone acetate
tert-butyl alcohol
17-acetoxy-6α-methyl-pregna-1,4-diene-3,20-dione
Medroxyprogesterone acetate
17α-acetoxy-3α-hydroxy-6α-methyl-5α-pregnan-20-one
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: lithium tri-t-butoxyaluminium hydride / tetrahydrofuran / 0 °C 2: 47 mg / H2 / Rh-C / ethanol; acetic acid / 48 h View Scheme |
The Molecular Structure of Medroxyprogesterone Acetate (CAS NO.71-58-9):
Empirical Formula: C24H34O4
Molecular Weight: 386.5244
Appearance: white crystalline powder
Nominal Mass: 386
Average Mass: 386.5244
Monoisotopic Mass: 386.24571
Index of Refraction: 1.538
Molar Refractivity: 106.71 cm3
Molar Volume: 340.8 cm3
Surface Tension: 43.2 dyne/cm
Density: 1.13 g/cm3
Flash Point: 213.2 °C
Enthalpy of Vaporization: 76.41 kJ/mol
Boiling Point: 496.4 °C at 760 mmHg
Vapour Pressure: 5.44E-10 mmHg at 25 °C
Water Solubility: <0.1 g/100 mL at 23 °C
Melting Point: 206-207 °C
Stability: Stable, but weakly air and light sensitive. Incompatible with strong oxidizing agents
Classification Code: Antineoplastic Agents; Antineoplastic agents, hormonal; Contraceptive Agents; Contraceptive agents, female; Contraceptive agents, male; Drug / Therapeutic Agent; Hormone; Human Data; Mutation data; Progestin; Reproductive Control Agents; Reproductive Effect; Tumor data
IUPAC Name: [(6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
Synonyms: (6-Alpha)-17-(acetyloxy)-6-methylpreg-4-ene-3,20-dione ; 17-(Acetyloxy)-6-methyl-(6-alpha)-pregn-4-ene-20-dione ; 17-(Acetyloxy)-6-methyl-20-dion(6alpha)-pregn-4-ene- ; 17-Acetoxy-6-alpha-methylprogesterone ; 17-Alpha-hydroxy-6-alpha-methylpregn-4-ene-3,20-dioneacetate ; 17-Alpha-hydroxy-6-alpha-methyl-progesteronacetate ; 17-Alpha-hydroxy-6-alpha-methylprogesteroneacetate ; 17-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dioneacetate
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source dog LD50 oral > 5gm/kg (5000mg/kg) Drugs in Japan Vol. -, Pg. 1196, 1990. mouse LD50 intraperitoneal > 1500mg/kg (1500mg/kg) Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984. mouse LD50 oral > 16gm/kg (16000mg/kg) ENDOCRINE: ADRENAL CORTEX HYPOPLASIA Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984. mouse LD50 subcutaneous > 1500mg/kg (1500mg/kg) Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984. rat LD50 intraperitoneal > 900mg/kg (900mg/kg) Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984. rat LD50 oral > 6400mg/kg (6400mg/kg) LIVER: OTHER CHANGES Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984. rat LD50 subcutaneous > 900mg/kg (900mg/kg) Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984. women TDLo intravenous 10mg/kg (10mg/kg) SENSE ORGANS AND SPECIAL SENSES: INCREASED INTRAOCULAR PRESSURE: EYE Advances in Planned Parenthood. Vol. 8, Pg. 103, 1972. women TDLo intravenous 21mg/kg (21mg/kg) SENSE ORGANS AND SPECIAL SENSES: INCREASED INTRAOCULAR PRESSURE: EYE Advances in Planned Parenthood. Vol. 8, Pg. 103, 1972.
Hazard Codes: Xn
Risk Statements: 40-48
R40: Limited evidence of a carcinogenic effect
R48: Danger of serious damage to health by prolonged exposur
Safety Statements: 22-36/37/39-45
S22: Do not breathe dust
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
WGK Germany: 3
RTECS: TU5010000
Incompatibilities: Flammable and/or toxic gases are generated by combination with with alkali metals, nitrides, and strong reducing agents Reacts with oxoacids and carboxylic acids to form esters plus water Incompatible with oxidizing agents.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View